[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
July 1969

Treatment of Pemphigus Vulgaris With Methotrexate

Author Affiliations


From the Department of Dermatology, Tufts University School of Medicine and the New England Medical Center, Boston.

Arch Dermatol. 1969;100(1):70-78. doi:10.1001/archderm.1969.01610250076018

Five patients with pemphigus vulgaris were treated with the immunosuppressive drug, methotrexate. Treatment was effective in three patients in whom the disease previously had been held in nearly complete remission by maintenance doses of prednisone. Also, good results were obtained in one patient who was in the very early stage of the disease. The toxicity of methotrexate limited, however, its usefulness in one patient with very active pemphigus vulgaris since very high doses appear to be necessary for an adequate control of the disease.